Peripherally administered liraglutide has recently been shown to gain access into certain areas of the brain with the majority entering the ARC and median eminence with smaller amounts in the PVN (Secher et al., 2014)
Cardiovascular safety data is favorable: the SUSTAIN-6 trial showed semaglutide reduced major adverse cardiac events by 26% in patients with established heart disease or diabetes
ecnoglutide is SC-only Geographic focus : Ecnoglutide development focused on China
Manage Side Effects Proactively While side effects like nausea from Semaglutide are often mild and tend to decrease over time, there are effective strategies to mitigate them
Its often overlooked, but some of the most cited clinical trials of GLP-1s (like the SELECT and SURMOUNT trials) included lifestyle interventions
If its cloudy, discolored, or has visible particles, discard it